NFE2L3 was expressed at higher levels in single cells of AML, CML, BRCA, AST, GBM, glioma, ODG, RCC, and MEL monocyte samples however, it was expressed at lower levels in single cells of HNSCC, RB, and UM samples (Figures 9B–M). This evidence concerns the gene NFE2L3 and chronic myelogenous leukemia, BCR-ABL1 positive.